💻
💻 Technology
Anthropic acquires one-person biotech AI firm to discover new drugs
Anthropic bought Mithril Medicine of Cambridge, Massachusetts — a biotech company employing one full-time employee that, with AI support, developed two antibodies to treat a rare form of muscular dystrophy. The acquisition has sparked debate about whether one-person, AI-assisted biotech companies represent the future of drug discovery. Experts note that despite minimal staffing, Mithril relied on many external labs and consultants. Anthropic aims to expand into biomedical research.
Comments
No comments yet
Comments
No comments yet — be the first to weigh in 👇
No comments yet. Be the first!